167 related articles for article (PubMed ID: 15194999)
21. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.
Besic N; Auersperg M; Golouh R
Eur J Surg Oncol; 1999 Dec; 25(6):599-605. PubMed ID: 10556007
[TBL] [Abstract][Full Text] [Related]
22. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
[TBL] [Abstract][Full Text] [Related]
23. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
24. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
Schlumberger M; Arcangioli O; Piekarski JD; Tubiana M; Parmentier C
J Nucl Med; 1988 Nov; 29(11):1790-4. PubMed ID: 3183748
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
[TBL] [Abstract][Full Text] [Related]
26. Treatment of thyroid cancer based on risk groups.
Shaha A
J Surg Oncol; 2006 Dec; 94(8):683-91. PubMed ID: 17131422
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
[TBL] [Abstract][Full Text] [Related]
28. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
29. [Should cervical lymph nodes be electively removed in differentiated thyroid carcinoma?].
Herman K; Wysocki W; Fortuna J
Wiad Lek; 2001; 54 Suppl 1():205-9. PubMed ID: 12182026
[TBL] [Abstract][Full Text] [Related]
30. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
[TBL] [Abstract][Full Text] [Related]
31. Cause of death in patients with well-differentiated thyroid carcinoma.
Beasley NJ; Walfish PG; Witterick I; Freeman JL
Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
[TBL] [Abstract][Full Text] [Related]
32. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
33. Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma.
Collini P; Sampietro G; Rosai J; Pilotti S
Virchows Arch; 2003 Jan; 442(1):71-6. PubMed ID: 12536317
[TBL] [Abstract][Full Text] [Related]
34. Hierarchy of treatment variables affecting outcome of 131I therapy in thyroid cancer patients with lung metastases.
Kozak OV; Sukach GG; Korchinskaya OI; Trembach AM; Turicina VL; Voit NU
Exp Oncol; 2005 Jun; 27(2):150-5. PubMed ID: 15995635
[TBL] [Abstract][Full Text] [Related]
35. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
37. Specific features of differentiated thyroid carcinoma in patients over 70 years of age.
Biliotti GC; Martini F; Vezzosi V; Seghi P; Tozzi F; Castagnoli A; Basili G; Peri A
J Surg Oncol; 2006 Mar; 93(3):194-8. PubMed ID: 16482598
[TBL] [Abstract][Full Text] [Related]
38. Population-based outcomes for pediatric thyroid carcinoma.
Shapiro NL; Bhattacharyya N
Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
[TBL] [Abstract][Full Text] [Related]
39. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
40. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
